Kay Warner is a Senior Director within the Patients in Partnership team at GlaxoSmithKline Research and Development and is a patient engagement subject matter expert at GSK.
With her passion to make a difference in research and development, Kay has spent the last 16 years of her career working to strengthen the patient voice in medicines development and research at key decision time points. Her work has included interaction with individual patients, caregivers, patient advocates, patient advocacy organisations and health care providers.
She also represents GSK in the European Patients’ Academy (EUPATI) project. She is also supporting the IMI2 project Patients Active in Research and Dialogues for an Improved Generation of Medicines (PARADIGM).
We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer.The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.